
MediMabBio
Developer of healthcare immunotherapies designed to treat serious diseases such as cancer and autoimmune disorders. The company offers engineered monoclonal antibodies, cytokine-antibody fusion protei...
Valuation
$0
Share Price
N/A
Total Raised
$37.9M
Last Round
N/A